Supplemental Reading for Chapter 1 Basic Principles of Clinical ...

50. Katz B, Rosenberg A, Frishman WH: Controlledrelease
drug delivery systems in cardiovascular
medicine. Am Heart J 129:359, 1995.
51. Plosker GL, Faulds D: Nisoldipine coat-core. Drugs
52:232, 1996.
52. White WB: A chronotherapeutic approach to the
management of hypertension. Am J Hypertens
9:29S, 1996.
53. Frishman WH, Kirstein E, Klein M, et al: Clinical
relevance of verapamil plasma levels in stable angina
pectoris. Am J Cardiol 50:1180, 1982.
54. Frishman WH, Charlap S, Kimmel B, et al: Diltiazem
compared to nifedipine and combination
treatment in patients with stable angina: Effects
on angina, exercise tolerance and the ambulatory
ECG. Circulation 77:774, 1988.
55. Sica DA, Gehr TWB: Calcium-channel blockers
and the cytochrome P450 system. In: Epstein M,
ed: Calcium Antagonists in Clinical Medicine, 3rd
ed. Philadelphia: Hanley and Belfus, 2002:93.
56. Sica DA, Gehr TWB: Calcium-channel blockers
and end-stage renal disease. In: Epstein M, ed.
Calcium Antagonists in Clinical Medicine, 3rd ed.
Philadelphia: Hanley and Belfus, 2002:701.
57. Singh BN, Chew CYC, Josephson MA, et al: Hemodynamic
mechanisms underlying the antianginal
actions of verapamil. Am J Cardiol 50:886, 1982.
58. Opie LH: Calcium channel antagonists in the treatment
of coronary artery disease: Fundamental
pharmacological properties relevant to clinical use.
Prog Cardiovasc Dis 38(4):273, 1996.
59. Pepine CJ, Lambert CR: Usefulness of nicardipine
for angina pectoris. Am J Cardiol 59:13J, 1987.
60. Scheidt S, Frishman WH, Packer M, et al: Longterm
effectiveness of verapamil in stable and unstable
angina pectoris: One year follow-up of patients
treated-controlled double-blind randomized clinical
trials. Am J Cardiol 50:1185, 1982.
61. Opie LH: Calcium channel antagonists in the management
of anginal syndromes: Changing concepts
in relation to the role of coronary vasospasm. Prog
Cardiovasc Dis 38:291, 1996.
62. Frishman WH, Klein NA, Strom JA, et al: Superiority
of verapamil to propranolol in stable angina
pectoris—a double-blind, randomized crossover
trial. Circulation 65(Suppl I):151, 1982.
63. Frishman WH, Klein N, Klein P, et al: Comparison
of oral propranolol and verapamil for combined
systemic hypertension and angina pectoris: A placebo-controlled
double-blind randomized crossover
trial. Am J Cardiol 50:1164, 1982.
64. Frishman WH, Charlap S: Calcium-channel blockers
for combined systemic hypertension and myocardial
ischemia. Circulation 75:V154, 1988.
References to Chapter 8 8-3
65. Abrams J, Frishman WH, Bates SM, et al: Pharmacologic
options for treatment of ischemic disease.
In: Antman EM, ed. Cardiovascular Therapeutics,
3rd ed. Philadelphia: Saunders, 2007: 77.
66. Kizer JR, Kimmel SE: Epidemiologic review of the
calcium channel blocker drugs. An up-to-date perspective
on the proposed hazards. Arch Intern Med
161:1145, 2001.
67. Stone PH, Gibson RS, Glasser SP, et al: Comparison
of propranolol, diltiazem, and nifedipine in the
treatment of ambulatory ischemia in patients with
stable angina: Differential effects on ambulatory
ischemia, exercise performance, and anginal symptoms.
Circulation 82:1962, 1990.
68. Frishman WH, Glasser S, Stone P, et al: Comparison
of controlled-onset extended-release verapamil
to amlodipine and amlodipine plus atenolol on exercise
performance and ambulatory ischemia in
patients with chronic stable angina pectoris. Am J
Cardiol 83:507, 1999.
69. Johnson SM, Mauritson DR, Willerson JT, et al: A
controlled trial of verapamil for Prinzmetal’s variant
angina. N Engl J Med 304:862, 1981.
70. Antman E, Muller JE, Goldberg S, et al: Nifedipine
therapy for coronary artery spasm experience in
127 patients. N Engl J Med 302:1269, 1980.
71. Schroeder JS, Feldman RL, Giles TD, et al: Multiclinic
controlled trial of diltiazem for Prinzmetals
angina. Am J Med 72:227, 1982.
72. Chahine RA, Feldman RL, Giles TD, et al: Randomized
placebo controlled trial of amlodipine
in vasospastic angina. J Am Coll Cardiol 21:1365,
1993.
73. Parodi O, Simonetti I, LAbbate A, et al: Comparative
effectiveness of verapamil and propranolol in
angina at rest. Am J Cardiol 50:923, 1982.
74. Johnson SM, Mauritson DR, Willerson JT, et al:
Comparison of verapamil and nifedipine in the
treatment of variant angina pectoris: preliminary
observations in 10 patients. Am J Cardiol 47:1295,
1981.
75. Gerstenblith G, Ouyang P, Achuff S, et al: Nifedipine
in unstable angina: a double-blind randomized
trial. N Engl J Med 306:885, 1982.
76. Anderson JL, Adams CD, Antman EM et al. ACC/
AHA 2007 guidelines for the management of patients
with unstable angina/non-ST-segment elevation
myocardial infarction: a report of the
American College of Cardiology/American Heart
Association Task Force on Practice Guidelines
(Writing committee to revise the 2002 guidelines
for the management of patients with unstable angina/non-ST-elevation
myocardial infarction)
developed in collaboration with the American